Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning – is there still an upper age limit? A focus on myeloid neoplasia-Reference-Cited by-同舟云学术

Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning – is there still an upper age limit? A focus on myeloid neoplasia

Published:2007-05-17 Issue:7 Volume:21 Page:1357-1362
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Finke J,Nagler A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404741.pdf

Reference45 articles.

1. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 1979; 301: 597–599.

2. Buckner CD, Clift RA, Thomas ED, Sanders JE, Stewart PS, Storb R et al. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. Leuk Res 1982; 6: 389–394.

3. Clift RA, Buckner CD, Appelbaum FR, Sullivan KM, Storb R, Thomas ED . Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood 1998; 92: 1455–1456.

4. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE et al. Age and acute myeloid leukemia. Blood 2006; 107: 3481–3485.

5. Farag SS, Archer KJ, Mrozek K, Ruppert AS, Carroll AJ, Vardiman JW et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood 2006; 108: 63–73.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zelluläre Therapien im Alter: Everything, everywhere, all at once?;InFo Hämatologie + Onkologie;2024-07

2. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis;Bone Marrow Transplantation;2022-04-02

3. How old is too old for a transplant?;Best Practice & Research Clinical Haematology;2021-03

4. Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2017-05-03

5. Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia;Blood Cancer Journal;2016-07